AMIDE COMPOUND HAVING BET PROTEOLYSIS-INDUCING ACTION AND MEDICINAL APPLICATION THEREOF
申请人:Mitsubishi Tanabe Pharma Corporation
公开号:EP3819305A1
公开(公告)日:2021-05-12
Provided are a compound superior in a cytotoxic action on cancer cells, an action inducing degradation of BET protein in cancer cells, and an inhibitory action on the binding of BET protein and acetylated histone, and useful as an anticancer agent, a BET protein degradation inducer or a BET protein inhibitor. A compound represented by the following formula (I)
wherein each symbol is as defined in the specification, or a pharmacologically acceptable salt thereof
本发明提供了一种化合物,该化合物对癌细胞具有卓越的细胞毒性作用、诱导癌细胞中 BET 蛋白降解的作用以及抑制 BET 蛋白与乙酰化组蛋白结合的作用,可用作抗癌剂、BET 蛋白降解诱导剂或 BET 蛋白抑制剂。下式(I)代表的化合物
其中各符号如说明书中所定义,或其药理上可接受的盐